Connect your AI

Oscar Health OSCR Inducement Payment For Convertible Note Conversion

Inducement Payment For Convertible Note Conversion at other companies

Halozyme TherapeuticsHALO

$1.37M—

Ionis PharmaceuticalsIONS

$4.09M—

Ionis PharmaceuticalsIONS

$4.09M—

Royal Caribbean GroupRCL

$0-100%

Bloom EnergyBE

$16.56M—

GlaukosGKOS

$18.01M—

Other financials

Income statement

Revenue$4.6B+52.6%

Operating income$704.1M+137%

Net income$679.0M+147%

EPS (diluted)$2.07+125%

Balance sheet

Cash & equivalents$4.8B+114%

Total debt$430.9M+43.7%

Total equity$1.7B+24.8%

Total assets$9.3B+59.0%

Cash flow

Operating cash flow$2.6B+198%

CapEx$8.8M-2.6%

Free cash flow$2.6B+200%

Valuation

Market cap$8.56B+4.0%

Enterprise value$4.16B-174%

P/S0.6×-0.2×

Profitability

Operating margin0.1%—

Net margin-0.3%—

FCF margin-8.2%—

Returns & leverage

Return on equity-2.6%—

Debt / equity0.3×0.0×

Current ratio1.1×+0.2×

Where this comes from

Reported directly by Oscar Health in its filing.

Tagged under the XBRL concept oscr:InducementPaymentForConvertibleNoteConversion.

The official record: Oscar Health’s 10-K, filed February 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oscar Health's inducement payment for convertible note conversion.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Oscar Health's inducement payment for convertible note conversion?: Oscar Health (OSCR) reported inducement payment for convertible note conversion of $1.11M in Q4 2025.
What does inducement payment for convertible note conversion mean?: Represents cash payments made to incentivize holders of convertible notes to convert their debt into equity. This is often used to reduce debt obligations and interest expenses. It reflects a strategic move to clean up the balance sheet.